多数寻找公司战略的人带着业务单元问题而来，而两者答案相反。 对 B2B SaaS 公司而言，问题集中在特定位置。承载答案的数字是净收入留存率和 CAC 回本期，行业特有难点是增长已从 42% 降至 32%，而 60% 的收入落在经济性最差的细分中。这个问题的通用版本与你实际面对的版本，第一步动作不同。
多数寻找公司战略的人带着业务单元问题而来，而两者答案相反。 对 B2B SaaS 公司而言，问题集中在特定位置。承载答案的数字是净收入留存率和 CAC 回本期，行业特有难点是增长已从 42% 降至 32%，而 60% 的收入落在经济性最差的细分中。这个问题的通用版本与你实际面对的版本，第一步动作不同。
这一区分并非学术问题。公司战略回答去哪里竞争：保留哪些市场和业务、收购什么、出售什么、资本如何在单元间流动，以及集团中心做了什么来证明其成本合理。业务单元战略回答如何取胜：定位、定价、细分、成本结构，以及具体竞争对手正在抢走具体客户。两者都成立，但使用不同证据，产生不同决策。
两者容易混淆的原因是症状往往相同。合并收入持平，看起来像一个单元表现不佳，也像组合已漂移到三个互不相关的业务。检验方法是拆分数据：若各单元表现均匀，则是在单一市场存在竞争问题，组合视角无法发现；若平均数由一个单元支撑另外两个，则是组合问题，再多弱势单元的竞争分析也解决不了。
公司战略的第二个用途，也是最常被跳过的，是母公司问题——集团中心能增加什么价值。集团中心要么比市场更好地配置资本，要么提供单元单独买不到的能力，要么施加单元不会自己施加的纪律。若三者都不做，它就是单元的税，诚实的战略答案可能是缩减而非重新定位它。
公司战略与转型（目录 id t5）运行组合算术——各单元的资本回报率、贡献与消耗资本的对比、各单元实际承担的间接费用——并给出配置视图。若答案最终是单一市场的竞争问题，它会直接指出，而非用组合语言包装定位问题。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 集团结果持平，各单元走势不一致
✓ 无人能说出集团中心做了什么、单元自己买不到
✓ 资本配置大致按去年比例，而非按回报
通常会让情况更糟的做法。 对实际为单一业务的公司做组合审查，得出剥离即将成为答案的那部分业务的建议。
It is for you if you run or finance a B2B SaaS company and the group result is flat and the units inside it are not moving together. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家 B2B SaaS 公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Pricing Strategy · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 公司战略与转型, one of 29 engagements the platform runs. For B2B SaaS 公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
公司战略决定进入哪些业务以及资本如何在它们之间流动。业务战略决定在其中一个业务里如何取胜。单一市场公司没有值得付费的公司战略问题，它有的是竞争问题。拥有三个单元和一张资产负债表的集团两者都有，按错误顺序回答是常见失败原因。
大型公司的组合审查通常为 £150k–£500k，周期八到十二周；精品和独立顾问做较窄版本收费 £40k–£120k。差异几乎完全来自初级数据收集的范围。若你的财务系统已能按单元产出贡献和资本，大部分费用只是购买你已持有的数字的分析。
作为总结，是；作为决策规则，不是。增长和份额是两个相关变量，也是最容易获取的两个，这就是矩阵留存的原因。当一个份额不高的单元正在产生支撑其余部分的现金，而矩阵建议剥离它时，就会误导。把它用来组织对话，然后按消耗资本的回报决定。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית